Core Laboratories Nv Stock Buy Hold or Sell Recommendation
| CLB Stock | USD 16.99 0.02 0.12% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Core Laboratories NV is 'Cautious Hold'. Macroaxis provides Core Laboratories buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CLB positions. The advice algorithm takes into account all of Core Laboratories' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Core Laboratories' buy or sell advice are summarized below:
Real Value 19.76 | Hype Value 16.53 | Market Value 16.99 | Naive Value 16.25 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Core Laboratories NV given historical horizon and risk tolerance towards Core Laboratories. When Macroaxis issues a 'buy' or 'sell' recommendation for Core Laboratories NV, the advice is generated through an automated system that utilizes algorithms and statistical models.
Core |
Execute Core Laboratories Buy or Sell Advice
The Core recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Core Laboratories NV. Macroaxis does not own or have any residual interests in Core Laboratories NV or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Core Laboratories' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Core Laboratories Trading Alerts and Improvement Suggestions
| Core Laboratories generated a negative expected return over the last 90 days | |
| Core Laboratories has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| On 4th of March 2024 Core Laboratories paid $ 0.01 per share dividend to its current shareholders |
Core Laboratories Returns Distribution Density
The distribution of Core Laboratories' historical returns is an attempt to chart the uncertainty of Core Laboratories' future price movements. The chart of the probability distribution of Core Laboratories daily returns describes the distribution of returns around its average expected value. We use Core Laboratories NV price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Core Laboratories returns is essential to provide solid investment advice for Core Laboratories.
| Mean Return | -0.0038 | Value At Risk | -3.61 | Potential Upside | 3.06 | Standard Deviation | 2.17 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Core Laboratories historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Core Laboratories Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Core Laboratories or Energy Equipment & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Core Laboratories' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Core stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.09 | |
β | Beta against NYSE Composite | 1.01 | |
σ | Overall volatility | 2.17 | |
Ir | Information ratio | -0.04 |
Core Laboratories Volatility Alert
Core Laboratories NV exhibits very low volatility with skewness of -0.02 and kurtosis of 0.27. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Core Laboratories' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Core Laboratories' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Core Laboratories Fundamentals Vs Peers
Comparing Core Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Core Laboratories' direct or indirect competition across all of the common fundamentals between Core Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as Core Laboratories or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Core Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Core Laboratories to competition |
| Fundamentals | Core Laboratories | Peer Average |
| Return On Equity | 0.18 | -0.31 |
| Return On Asset | 0.0605 | -0.14 |
| Profit Margin | 0.07 % | (1.27) % |
| Operating Margin | 0.13 % | (5.51) % |
| Current Valuation | 1 B | 16.62 B |
| Shares Outstanding | 46.66 M | 571.82 M |
| Shares Owned By Insiders | 0.85 % | 10.09 % |
| Shares Owned By Institutions | 99.15 % | 39.21 % |
| Number Of Shares Shorted | 6.59 M | 4.71 M |
| Price To Earning | 101.74 X | 28.72 X |
| Price To Book | 4.18 X | 9.51 X |
| Price To Sales | 1.60 X | 11.42 X |
| Revenue | 509.79 M | 9.43 B |
| Gross Profit | 96.08 M | 27.38 B |
| EBITDA | 69.57 M | 3.9 B |
| Net Income | 36.67 M | 570.98 M |
| Cash And Equivalents | 15.43 M | 2.7 B |
| Cash Per Share | 0.29 X | 5.01 X |
| Total Debt | 215.38 M | 5.32 B |
| Debt To Equity | 1.29 % | 48.70 % |
| Current Ratio | 2.23 X | 2.16 X |
| Book Value Per Share | 4.80 X | 1.93 K |
| Cash Flow From Operations | 24.79 M | 971.22 M |
| Short Ratio | 17.61 X | 4.00 X |
| Earnings Per Share | 0.51 X | 3.12 X |
| Price To Earnings To Growth | 2.15 X | 4.89 X |
| Target Price | 19.38 | |
| Number Of Employees | 3.6 K | 18.84 K |
| Beta | 2.43 | -0.15 |
| Market Capitalization | 792.83 M | 19.03 B |
| Total Asset | 586.39 M | 29.47 B |
| Retained Earnings | 120.76 M | 9.33 B |
| Working Capital | 108.57 M | 1.48 B |
Note: Acquisition by Mark Tattoli of 38002 shares of Core Laboratories subject to Rule 16b-3 [view details]
Core Laboratories Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Core . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Core Laboratories Buy or Sell Advice
When is the right time to buy or sell Core Laboratories NV? Buying financial instruments such as Core Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Core Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Management Thematic Idea Now
Health Management
Major hospitals and healthcare providers. The Health Management theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Core Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.